DawMed Systems PLC
07 February 2006
DAWMED
For Immediate Release:
DAWMED SYSTEMS PLC
Director's Shareholdings
On 3 February 2006 A J Bell Limited, as Trustees for the Gordon Francis Arbib
Self Invested Personal Pension scheme, purchased 150,000 Ordinary Shares of 5p
each at 12.25p per share. Gordon Arbib is a Non-Executive Director of the
Company and his underlying interest in the share capital of the Company is now
as set out below.
As a result of this purchase, the Company has received notices pursuant to
Sections 198 and 324 of the Companies Act 1985 from the following director and
other shareholder in the Company as follows:
Number of
Ordinary Shares
Gordon F Arbib
Shares 1,800,000 Ordinary Shares of
5p each
Option 300,000 Ordinary Shares of
5p each
A.J.Bell Limited (as Trustee of the Gordon __150,000 Ordinary Shares of
Francis Arbib SIPP) 5p each
2,250,000
Representing in aggregate 10.99 % of the Company's issued share capital.
7 February 2006
Enquiries: Kevin Gilmore
Executive Chairman
DawMed Systems plc 01789 740010
Roland Cornish
Chairman
Beaumont Cornish Limited 020 7628 3396
Maxine Barnes/Dominic Barretto
Bishopsgate Communications Limited 020 7430 1600
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.